Cargando…

Pharmacological treatment strategies for antipsychotic-induced hyperprolactinemia: a systematic review and network meta-analysis

Antipsychotic-induced hyperprolactinemia (AP-induced HPRL) occurs overall in up to 70% of patients with schizophrenia, which is associated with hypogonadism and sexual dysfunction. We summarized the latest evidence for the benefits of prolactin-lowering drugs. We performed network meta-analyses to s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Zhe, Sun, Yaoyao, Zhang, Yuyanan, Chen, Yu, Guo, Liangkun, Liao, Yundan, Kang, Zhewei, Feng, Xiaoyang, Yue, Weihua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256633/ https://www.ncbi.nlm.nih.gov/pubmed/35790713 http://dx.doi.org/10.1038/s41398-022-02027-4

Ejemplares similares

Oxidative Stress and Psychiatric Disorders: Evidence from the Bidirectional Mendelian Randomization Study
por: Lu, Zhe, et al.
Publicado: (2022)

Dissecting the causal association between social or physical inactivity and depression: a bidirectional two-sample Mendelian Randomization study
por: Zhao, Guorui, et al.
Publicado: (2023)

Peripheral non-enzymatic antioxidants as biomarkers for mood disorders: Evidence from a machine learning prediction model
por: Gong, Yuandong, et al.
Publicado: (2022)

Management of antipsychotic-induced hyperprolactinemia
por: Tewksbury, Ashley, et al.
Publicado: (2016)

Multigenetic Pharmacogenomics–Guided Treatment vs Treatment As Usual Among Hospitalized Men With Schizophrenia: A Randomized Clinical Trial
por: Kang, Zhewei, et al.
Publicado: (2023)

ATAD3B and SKIL polymorphisms associated with antipsychotic-induced QTc interval change in patients with schizophrenia: a genome-wide association study
por: Lu, Zhe, et al.
Publicado: (2022)

Hyperprolactinemia with Antipsychotic Drugs in Children and Adolescents
por: Rosenbloom, Arlan L.
Publicado: (2010)

Antipsychotics-induced hyperprolactinemia and screening for macroprolactin
por: Ruljancic, Nedjeljka, et al.
Publicado: (2020)

Association of NKAPL rs1635 With Cognitive Function in Early-Onset Schizophrenia
por: Yang, Yang, et al.
Publicado: (2022)

Pharmacological causes of hyperprolactinemia
por: Torre, Daria La, et al.
Publicado: (2007)

Correction: Hyperprolactinemia with antipsychotic drugs in children and adolescents
por: Rosenbloom, Arlan L
Publicado: (2013)

Hyperprolactinemia with antipsychotics and the need for magnetic resonance imaging
por: Molina Liétor, M.D.C., et al.
Publicado: (2022)

Hormonal alterations due to antipsychotic-related hyperprolactinemia
por: Montejo, A.L., et al.
Publicado: (2022)

Reversal of symptomatic antipsychotic-induced hyperprolactinemia with addition of aripiprazole
por: Kotorki, Paraskevi, et al.
Publicado: (2010)

Association of ANKK1 polymorphism with antipsychotic‐induced hyperprolactinemia
por: Fedorenko, Olga Yu., et al.
Publicado: (2020)

Hyperprolactinemia during antipsychotics treatment increases the level of coagulation markers
por: Ishioka, Masamichi, et al.
Publicado: (2015)

Add-on Aripiprazole for Atypical Antipsychotic-induced, Clinically Significant Hyperprolactinemia
por: Raveendranthan, Dhanya, et al.
Publicado: (2018)

Development of a Guideline for Antipsychotic-induced Hyperprolactinemia in Korea Using the ADAPTE Process
por: Kim, Hye Ri, et al.
Publicado: (2023)

Adjunctive Aripiprazole Versus Placebo for Antipsychotic-Induced Hyperprolactinemia: Meta-Analysis of Randomized Controlled Trials
por: Li, Xianbin, et al.
Publicado: (2013)

Using aripiprazole to reduce antipsychotic-induced hyperprolactinemia: meta-analysis of currently available randomized controlled trials
por: MENG, Meiling, et al.
Publicado: (2015)

A Comment on “Add-on Aripiprazole for Atypical Antipsychotic-induced, Clinically Significant Hyperprolactinemia”
por: Naguy, Ahmed
Publicado: (2018)

Hyperprolactinemia
por: Majumdar, Abha, et al.
Publicado: (2013)

Progressive Grey Matter Volume Changes in Patients with Schizophrenia over 6 Weeks of Antipsychotic Treatment and Their Relationship to Clinical Improvement
por: Zhang, Xiao, et al.
Publicado: (2018)

PM403. Comparison between addition of and switching to aripiprazole for resolving antipsychotic-induced hyperprolactinemia
por: Lee, Jung Suk, et al.
Publicado: (2016)

Hyperprolactinemia in patients taking antipsychotics: the importance of a shared approach between psychiatry and endocrinology
por: Mousinho, M., et al.
Publicado: (2023)

Efficacy and Safety of Adjunctive Aripiprazole, Metformin, and Paeoniae–Glycyrrhiza Decoction for Antipsychotic-Induced Hyperprolactinemia: A Network Meta-Analysis of Randomized Controlled Trials
por: Zhang, Ling, et al.
Publicado: (2021)

Peony-Glycyrrhiza Decoction for Antipsychotic-Related Hyperprolactinemia in Patients with Schizophrenia: A Randomized Controlled Trial
por: Wang, Zhongbao, et al.
Publicado: (2023)

Teratogenicity and hyperprolactinemia
por: Andrade, Chittaranjan
Publicado: (2009)

Association of MTHFR C677T Polymorphism With Antipsychotic-Induced Change of Weight and Metabolism Index
por: Su, Yi, et al.
Publicado: (2021)

High-risk group and functional subtypes of non-suicidal self-injury in young adults with mental disorders
por: Yan, Huiru, et al.
Publicado: (2023)

Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions
por: Johnston, A. N., et al.
Publicado: (2018)

Genome-wide association study identified six loci associated with adverse drug reactions to aripiprazole in schizophrenia patients
por: Wang, Xueping, et al.
Publicado: (2023)

Drug Induced Hyperprolactinemia
por: Venkatanarasu, Ashok, et al.
Publicado: (2021)

Pharmacological and non-pharmacological interventions to prevent delirium in critically ill patients: a systematic review and network meta-analysis
por: Burry, Lisa D., et al.
Publicado: (2021)

Network pharmacology-based strategy for predicting therapy targets of Sanqi and Huangjing in diabetes mellitus
por: Cui, Xiao-Yan, et al.
Publicado: (2022)

Treatment of hyperprolactinemia: a systematic review and meta-analysis
por: Wang, Amy T, et al.
Publicado: (2012)

Utility of Cannulated Prolactin to Exclude Stress Hyperprolactinemia in Patients with Persistent Mild Hyperprolactinemia
por: Almazrouei, Raya, et al.
Publicado: (2021)

PM515. The association between serotonin receptor gene polymorphisms and hyperprolactinemia in antipsychotic drug-treated schizophrenic patients
por: Ivanova, Svetlana, et al.
Publicado: (2016)

A pharmacogenetic study of patients with schizophrenia from West Siberia gets insight into dopaminergic mechanisms of antipsychotic-induced hyperprolactinemia
por: Osmanova, Diana Z., et al.
Publicado: (2019)

An Audit on the Monitoring and Management of Hyperprolactinemia in Inpatient Adults on Regular Antipsychotics in 8 Acute Wards in an NHS Mental Health Trust
por: Zhang, Peter, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i9hn2cs5d52oqdoreh07m2f2ls